BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18401884)

  • 1. Re: Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol 2006;20:300-304.
    Rashid T; Foley CL; Briggs TP
    J Endourol; 2008 Feb; 22(2):393. PubMed ID: 18401884
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol 2006;20:300-304.
    Rashid T; Foley CL; Briggs TP
    J Endourol; 2007 Jul; 21(7):795. PubMed ID: 17705774
    [No Abstract]   [Full Text] [Related]  

  • 3. Using two ipsilateral double j ureteral stents for extrinsic ureteral obstruction due to colon carcinoma.
    Kilciler M; Erdemir F; Bedir S; Coban H; Erten K; Ors O; Ozgok Y
    Urol Int; 2005; 75(4):319-21. PubMed ID: 16327298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: using two ipsilateral double J ureteral stents for extrinsic ureteral obstruction due to colon carcinoma.
    Gunendran T; Sinclair AM
    Urol Int; 2006; 77(4):375. PubMed ID: 17135792
    [No Abstract]   [Full Text] [Related]  

  • 5. Metal ureteral stent for benign and malignant ureteral obstruction.
    Benson AD; Taylor ER; Schwartz BF
    J Urol; 2011 Jun; 185(6):2217-22. PubMed ID: 21497845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of metallic stents for malignant ureteral obstruction in advanced cervical carcinoma.
    Lang EK; Winer AG; Abbey-Mensah G; Anne R; Allaei A; Friedman F; Thomas R; La Nasa J; Davis R
    J Endourol; 2013 May; 27(5):646-51. PubMed ID: 23199302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyelovesical bypass graft for palliative management of malignant ureteric obstruction: optimizing the technique by percutaneous access to the bladder using a split Amplatz sheath.
    Aminsharifi A; Taddayun A; Jafari M; Ghanbarifard E
    Urology; 2010 Oct; 76(4):993-5. PubMed ID: 20110107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.
    Patel C; Loughran D; Jones R; Abdulmajed M; Shergill I
    BMC Urol; 2017 Mar; 17(1):16. PubMed ID: 28283031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallic stents in gynecologic cancer: an approach to treat extrinsic ureteral obstruction.
    Barbalias GA; Liatsikos EN; Kalogeropoulou C; Karnabatidis D; Siablis D
    Eur Urol; 2000 Jul; 38(1):35-40. PubMed ID: 10859439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with full-length metal stent to relieve malignant ureteral obstruction.
    Borin JF; Melamud O; Clayman RV
    J Endourol; 2006 May; 20(5):300-4. PubMed ID: 16724898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis.
    Nagele U; Kuczyk MA; Horstmann M; Hennenlotter J; Sievert KD; Schilling D; Walcher U; Stenzl A; Anastasiadis AG
    World J Urol; 2008 Jun; 26(3):257-62. PubMed ID: 18324407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Transvesical Retrograde Ureteral Stent Insertion for Neoplastic Stricture.
    Slaba S; Zaarour Y; Smayra T
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):144-146. PubMed ID: 27460256
    [No Abstract]   [Full Text] [Related]  

  • 15. Success of ureteral stents for intrinsic ureteral obstruction.
    Wenzler DL; Kim SP; Rosevear HM; Faerber GJ; Roberts WW; Wolf JS
    J Endourol; 2008 Feb; 22(2):295-9. PubMed ID: 18294036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
    Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
    Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of resonance metallic stents for ureteral obstruction.
    Wang HJ; Lee TY; Luo HL; Chen CH; Shen YC; Chuang YC; Chiang PH
    BJU Int; 2011 Aug; 108(3):428-32. PubMed ID: 21062397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrograde stenting for obstruction of the renal transplant ureter.
    Gerrard ER; Burns JR; Young CJ; Urban DA; Hammontree LN; El-Galley R; Kolettis PN
    Urology; 2005 Aug; 66(2):256-60; discussion 260. PubMed ID: 16098351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents.
    Chow PM; Chiang IN; Chen CY; Huang KH; Hsu JS; Wang SM; Lee YJ; Yu HJ; Pu YS; Huang CY
    PLoS One; 2015; 10(8):e0135566. PubMed ID: 26267140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal stents: a new treatment of malignant ureteral obstruction.
    Barbalias GA; Siablis D; Liatsikos EN; Karnabatidis D; Yarmenitis S; Bouropoulos K; Dimopoulos J
    J Urol; 1997 Jul; 158(1):54-8. PubMed ID: 9186322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.